Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05762484Not yet recruiting
Randomised, open-label trial in hidradenitis suppurativa (HS) (2 arms), sponsored by Erasmus MC. Primary endpoint: Difference in International Hidradenitis Suppurativa Severity Score System over time. Planned start Apr 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05762484.